Key result
Orthogonal dual-device cardioversion improves sinus rhythm restoration ~24 percentage points over conventional shocks in persistent AF.
Why the study?
Transthoracic DC shocks fail to restore sinus rhythm in approximately 5 to 30% of AF patients. Whether delivering high-energy shocks at different axes using a single-device or dual-device orthogonal configuration improves cardioversion success compared with standard DC shocks was evaluated.
Does delivering high-energy shocks using a single-device or dual-device orthogonal configuration improve the success of electrical cardioversion to restore sinus rhythm compared with standard antero-lateral DC shocks in patients with persistent atrial fibrillation?
Does delivering high-energy shocks using a single-device or dual-device orthogonal configuration improve the success of electrical cardioversion to restore sinus rhythm compared with standard antero-lateral DC shocks in patients with persistent atrial fibrillation?
Double simultaneous DC shocks and single-device shocks in an orthogonal configuration significantly improve cardioversion success rates in persistent atrial fibrillation compared to standard antero-lateral shocks without increasing myocardial injury biomarkers.
May improve cardioversion success in persistent AF without biomarker rise; leaves open randomized confirmation before practice change.
Objective Atrial fibrillation (AF) is treated with DC shocks delivered transthoracically; however, in approximately 5 to 30% of patients, these shocks fail to restore sinus rhythm (SR). In this study, we aimed to evaluate whether delivering high-energy shocks at different axes using a single-device or dual-device orthogonal configuration could improve the success of cardioversion compared with standard DC shocks to restore SR. Method After TEE evaluation, 180 persistent AF patients were included in the study. In group 1, 50 patients underwent conventional DCCV; in group 2, 50 patients underwent orthogonal single-device DCCV; and in group 3, 80 patients underwent orthogonal dual-device DCCV. The conventional group DCCV electrode pads were positioned antero-lateral (Figure 1a). The orthogonal single-device group DCCV electrode pads were positioned antero-lateral and antero-posterior, and these pads were connected to a single defibrillator (Figure 1b). The orthogonal dual-device group DCCV electrode pads were positioned antero-lateral and antero-posterior, and these pads were connected to two defibrillators (Figure 1c). In conventional group; transthoracic electrical cardioversion was performed with delivery of synchronized biphasic DC shocks of 200, 200, and 270J using antero-lateral pads (Figure 1a,2). In orthogonal single-device group; transthoracic electrical cardioversion was performed with delivery of synchronized biphasic DC shocks of 200, 200, and 270J using antero-lateral and antero-posterior pads (Figure 1b,2). In the orthogonal dual-device group; transthoracic electrical cardioversion was performed with delivery of synchronized biphasic DC shocks of 100 + 100, 200 + 200, and 270 + 270J using antero-lateral and antero-posterior pads (Figure 1c,2). Cardioversion was considered successful if atrial P waves were unmistakably identified 5 min after the shock. Result The results of the study are shown in Figure 2. First DCCV shock success (conversion to SR) was significantly higher in group 3 than in group 1; in group 1: 70% vs in group 3: 85%; p=0.04, and in group 2; 80%. Second DCCV shock success was significantly higher in group 3 than in group 1 and 2; in group 1: 72% vs in group 3: 95 %; p<0.001, in group 2: 80% vs in group 3: 95%; p=0.007. Third DCCV shock success was significantly higher in group 2: 90% than in group 1: 74%; p=0.03, and in group 3: 97.5% than in group 1: 74%; p<0.001. CK, CK-MB, and hs-Troponin I levels were evaluated at baseline and at 6 and 12 hours after DCCV, and these parameters were similar among the three groups (p > 0.05). All patients who converted to SR remained in sinus rhythm until hospital discharge. Conclusion Double simultaneous DC shocks in an orthogonal configuration is an effective method than standart antero-lateral DC shocks for the cardioversion of persistant AF. These methods have similar safety.
No takes yet. Share an insight, caveat, or question.
Akpinar et al. (2026) studied Persistent atrial fibrillation (n=180). Orthogonal dual-device or single-device direct current cardioversion (DCCV) vs. Conventional antero-lateral direct current cardioversion (200J, 200J, and 270J) was evaluated on Cardioversion success (conversion to sinus rhythm with atrial P waves identified 5 min after the third shock) (p=<0.001). Orthogonal dual-device electrical cardioversion achieved higher overall sinus rhythm restoration than conventional antero-lateral shocks in persistent AF (97.5% vs 74%; p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: